1928 Diagnostics

About:

Fighting antibiotic resistance with DNA analytics

Website: http://www.1928diagnostics.com/

Twitter/X: 1928diagnostics

Top Investors: Chalmers Ventures AB, Sciety, EASME - EU Executive Agency for SMEs

Description:

1928 Diagnostics is a digital health company, crunching DNA data in the cloud, to enable healthcare providers fight antibiotic resistance. Our software service provide revolutionary outbreak tracing and diagnostics for full infection control at any hospital.

Total Funding Amount:

$9.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gothenburg, Vastra Gotaland, Sweden

Founded Date:

2014-01-01

Contact Email:

info(AT)1928diagnostics.com

Founders:

Kristina Lagerstedt, Susanne Staaf

Number of Employees:

11-50

Last Funding Date:

2024-04-09

IPO Status:

Private

Industries: